NIH

Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness. Read More

A research team led by Josh Peterson, M.D., MPH, assistant professor of Biomedical Informatics and Medicine, and John Graves, Ph.D., assistant professor of Preventive Medicine, will study the cost-effectiveness of testing patients’ risk of adverse gene-drug interactions. Read More

The hormone relaxin may offer a novel approach for treating diet-induced insulin resistance. Read More

Magnesium and vitamin D appear to work together to reduce risk of death from cardiovascular disease and colorectal cancer. Read More

Importin alpha 5, a member of a family of proteins that “shuttle” other proteins into the nucleus, is a potential new target for drugs to treat inflammatory diseases. Read More

Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies. Read More

Patients treated in intensive care units across the globe enter their medical care with no evidence of cognitive impairment but often leave with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer’s disease (AD) that persist for at least a year, according to a Vanderbilt University Medical Center study published today in the New England Journal of Medicine. Read More

Neuroscientists have identified the location in the brain's visual cortex responsible for generating a common perceptual illusion: seeing shapes and surfaces that don't really exist when viewing a fragmented background. Read More

Vanderbilt researchers used existing genome-wide association study datasets to identify gene interactions that contribute to tooth decay. Read More

A panel of metabolites – small molecules that are part of metabolic processes – that are unique to macular degeneration will shed light on the disease and aid diagnosis. Read More